178 related articles for article (PubMed ID: 37201441)
1. Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential driver genes.
Li S; Chen X; Chen J; Wu B; Liu J; Guo Y; Li M; Pu X
Comput Biol Med; 2023 Jul; 161():106988. PubMed ID: 37201441
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape.
Li S; Chen J; Chen X; Yu J; Guo Y; Li M; Pu X
Front Pharmacol; 2022; 13():997664. PubMed ID: 36110544
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
[TBL] [Abstract][Full Text] [Related]
4. GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
Sriram K; Moyung K; Corriden R; Carter H; Insel PA
PLoS Biol; 2019 Nov; 17(11):e3000434. PubMed ID: 31765370
[TBL] [Abstract][Full Text] [Related]
5. Interpretable meta-learning of multi-omics data for survival analysis and pathway enrichment.
Cho HJ; Shu M; Bekiranov S; Zang C; Zhang A
Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 36864611
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics integration method based on attention deep learning network for biomedical data classification.
Gong P; Cheng L; Zhang Z; Meng A; Li E; Chen J; Zhang L
Comput Methods Programs Biomed; 2023 Apr; 231():107377. PubMed ID: 36739624
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
8. Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.
Wu V; Yeerna H; Nohata N; Chiou J; Harismendy O; Raimondi F; Inoue A; Russell RB; Tamayo P; Gutkind JS
J Biol Chem; 2019 Jul; 294(29):11062-11086. PubMed ID: 31171722
[TBL] [Abstract][Full Text] [Related]
9. Adhesion family of G protein-coupled receptors and cancer.
Lin HH
Chang Gung Med J; 2012; 35(1):15-27. PubMed ID: 22483424
[TBL] [Abstract][Full Text] [Related]
10. Integration of incomplete multi-omics data using Knowledge Distillation and Supervised Variational Autoencoders for disease progression prediction.
Ranjbari S; Arslanturk S
J Biomed Inform; 2023 Nov; 147():104512. PubMed ID: 37813325
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors.
Bongers BJ; Gorostiola González M; Wang X; van Vlijmen HWT; Jespers W; Gutiérrez-de-Terán H; Ye K; IJzerman AP; Heitman LH; van Westen GJP
Sci Rep; 2022 Dec; 12(1):21534. PubMed ID: 36513718
[TBL] [Abstract][Full Text] [Related]
12. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis reveals critical metabolic regulators in bladder cancer.
Wei C; Deng C; Dong R; Hou Y; Wang M; Wang L; Hou T; Chen Z
Int Urol Nephrol; 2024 Mar; 56(3):923-934. PubMed ID: 37882969
[TBL] [Abstract][Full Text] [Related]
14. InDEP: an interpretable machine learning approach to predict cancer driver genes from multi-omics data.
Yang H; Liu Y; Yang Y; Li D; Wang Z
Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37649392
[TBL] [Abstract][Full Text] [Related]
15. DGMP: Identifying Cancer Driver Genes by Jointing DGCN and MLP from Multi-omics Genomic Data.
Zhang SW; Xu JY; Zhang T
Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):928-938. PubMed ID: 36464123
[TBL] [Abstract][Full Text] [Related]
16. Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors.
Huh E; Gallion J; Agosto MA; Wright SJ; Wensel TG; Lichtarge O
Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34916293
[TBL] [Abstract][Full Text] [Related]
17. Uncertainty-aware dynamic integration for multi-omics classification of tumors.
Du L; Liu C; Wei R; Chen J
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3301-3312. PubMed ID: 35925427
[TBL] [Abstract][Full Text] [Related]
18. DriverDBv4: a multi-omics integration database for cancer driver gene research.
Liu CH; Lai YL; Shen PC; Liu HC; Tsai MH; Wang YD; Lin WJ; Chen FH; Li CY; Wang SC; Hung MC; Cheng WC
Nucleic Acids Res; 2024 Jan; 52(D1):D1246-D1252. PubMed ID: 37956338
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
[TBL] [Abstract][Full Text] [Related]
20. Multi-Omics Data Analysis Identifies Prognostic Biomarkers across Cancers.
Demir Karaman E; Işık Z
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
